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A B S T R A C T
Although late sodium current (INa-late) has long been known to contribute to plateau formation of mammalian
cardiac action potentials, lately it was considered as possible target for antiarrhythmic drugs. However, many
aspects of this current are still poorly understood. The present work was designed to study the true proﬁle of INa-
late in canine and guinea pig ventricular cells and compare them to INa-late recorded in undiseased human hearts.
INa-late was deﬁned as a tetrodotoxin-sensitive current, recorded under action potential voltage clamp conditions
using either canonic- or self-action potentials as command signals. Under action potential voltage clamp con-
ditions the amplitude of canine and human INa-late monotonically decreased during the plateau (decrescendo-
proﬁle), in contrast to guinea pig, where its amplitude increased during the plateau (crescendo proﬁle). The
decrescendo-proﬁle of canine INa-late could not be converted to a crescendo-morphology by application of ramp-
like command voltages or command action potentials recorded from guinea pig cells. Conventional voltage
clamp experiments revealed that the crescendo INa-late proﬁle in guinea pig was due to the slower decay of INa-late
in this species. When action potentials were recorded from multicellular ventricular preparations with sharp
microelectrode, action potentials were shortened by tetrodotoxin, which eﬀect was the largest in human, while
smaller in canine, and the smallest in guinea pig preparations. It is concluded that important interspecies dif-
ferences exist in the behavior of INa-late. At present canine myocytes seem to represent the best model of human
ventricular cells regarding the properties of INa-late. These results should be taken into account when pharma-
cological studies with INa-late are interpreted and extrapolated to human. Accordingly, canine ventricular tissues
or myocytes are suggested for pharmacological studies with INa-late inhibitors or modiﬁers. Incorporation of
present data to human action potential models may yield a better understanding of the role of INa-late in action
potential morphology, arrhythmogenesis, and intracellular calcium dynamics.
1. Introduction
Although late Na+ current (INa-late) is an important current ﬂowing
during the action potential (AP) plateau in mammalian cardiomyocytes
with physiological and pathological signiﬁcance recognized long ago
[1–3], its pathophysiological role in LQT3 [4] and heart failure [5–8]
has been emphasized only in the last decades. INa-late - as an inward
current - contributes to plateau formation and is responsible for largely
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half of the transmembrane Na+ entry [9–11]. As a consequence, the
elevation of INa-late results in increased arrhythmia propensity (e.g. in
heart failure) including prolongation of the action potential duration
(APD), increased inhomogeneity of repolarization and occurrence of
early as well as delayed afterdepolarizations [5,12–14]. Therefore, as a
new concept, intensive eﬀorts were made recently to develop selective
inhibitors of INa-late [9,15,16].
Initially INa-late was believed to be a consequence of the overlapping
steady-state activation and inactivation functions of the Na+ current
(window Na+ current) [17], now it is better explained by the slow
inactivation kinetics of a small fraction of cardiac Na+ channels (mode-
II gating, bursting and late openings) [4,6]. In spite of its relative im-
portance, many aspects of INa-late are still poorly understood. In contrast
to the detailed data obtained in rabbit [18], guinea pig [19] and porcine
[20] myocytes, we have only a limited number of recordings of native
human and canine INa-late, since these experiments were typically per-
formed using conventional voltage clamp arrangements and many of
them at room temperature [7,8,21–23]. Self action potential voltage
clamp measurements, delivering the cell's own AP as a command signal,
are not available in the literature either for canine or human ventricular
cardiomyocytes. Since canine ventricular cells are believed to be a good
model for human ventricular myocytes in general regarding their cel-
lular electrophysiological properties [24–26], our goal was to monitor
and compare the proﬁles of INa-late in ventricular cells obtained from
canine, guinea pig and undiseased human hearts. The rationale of our
work is given by the very limited availibilty of undiseased human
ventricular tissues for experimental purposes, and our results show that
canine myocytes - but not guinea pig cells - are reasonably suitable
preparations for studying the properties of human INa-late.
2. Methods
2.1. Preparations
Adult mongrel dogs of either sex (35 animals) were anesthetized
with intramuscular injections of 10mg/kg ketamine hydrochloride
(Calypsol, Richter Gedeon, Hungary)+ 1mg/kg xylazine hydro-
chloride (Sedaxylan, Eurovet Animal Health BV, The Netherlands) ac-
cording to a protocol approved by the local Animal Care Committee
(license No: 9/2015/DEMÁB). All animal procedures conform to the
guidelines from Directive 2010/63/EU of the European Parliament on
the protection of animals used for scientiﬁc purposes. Bilateral pal-
pebral reﬂex, jaw tone and response to bilateral painful stimuli (toe
pinch) was assessed in every 2min to monitor the depth of anesthesia.
The surgical procedure started after the palpebral reﬂex and the with-
drawal response to painful stimuli had been absent on both sides, there
had been no immediate respiratory response to painful stimuli and
there had been a considerable drop in the jaw tone for at least 6 min
(three consecutive assessments).
Male guinea pigs (22 animals) were heparinized and anesthetized
with nembutal (100mg/kg i.p.). After achieving deep anesthesia the
hearts were rapidly removed and mounted on a Langendorﬀ apparatus
allowing for retrograde perfusion of the aorta.
Undiseased human hearts (n=5) were obtained from organ donors
who did not receive medication except furosemide, dobutamine or
plasma expanders. The valves were utilized for pulmonary and aortic
valve transplantation surgery, and the remaining unused ventricular
tissues were used for experimental purposes. After explantation, the
hearts were stored in cardioplegic solution at 5 °C prior to dissection.
The experimental protocols conform to the principles outlined in the
Declaration of Helsinki and were approved by the University of Szeged
and National Scientiﬁc and Research Ethical Review Boards (4991–0/
2010-1018EKU, 339/PI/010).
Left ventricular trabeculae were dissected from the hearts and were
used for recording of AP using sharp microelectrodes.
2.2. Isolation of cardiomyocytes
Single canine and human myocytes were obtained by enzymatic
dispersion using the segment perfusion technique, as described pre-
viously [27]. Brieﬂy, a wedge-shaped section of the ventricular wall
supplied by the left anterior descending coronary artery was cannu-
lated, dissected and perfused with a nominally Ca2+-free Joklik solu-
tion (Minimum Essential Medium Eagle, Joklik Modiﬁcation, Sigma-
Aldrich Co. St. Louis, MO, USA) for 5min. This was followed by 30min
long perfusion with Joklik solution supplemented with 1mg/ml col-
lagenase (Type II, Worthington Biochemical Co., Lakewood, NJ, USA;
representing ﬁnal activity of 224 U/ml) and 0.2% bovine serum al-
bumin (Fraction V., Sigma) containing 50 μM Ca2+. After this, normal
external Ca2+ concentration was gradually restored and cells were
stored in Minimum Essential Medium Eagle until use.
Guinea pig ventricular cells were obtained using a standard retro-
grade perfusion technique as previously described [19]. After mounting
the aorta on a Langendorﬀ device the heart was washed with oxyge-
nized Tyrode solution for 5min and further 3min with Ca-free Tyrode
solution to stop the heart. This superfusate was supplemented with
0.6 mg/ml collagenase (Type II, Worthington Biochemical Co., Lake-
wood, NJ, USA) and 0.05mg/ml protease (Type XIV, Sigma-Aldrich
Co., St. Louis, MO, USA). After this procedure the left ventricle was
minced into tissue chunks which were further incubated with enzyme
solution for approximately 1 h. After harvesting the cells the normal
external Ca2+ concentration was restored.
2.3. Electrophysiology
Cells were placed in a 1ml volume plexiglass chamber and con-
tinuously superfused with a modiﬁed Tyrode solution supplied by a
gravity driven system at a speed of 1–2ml/min. The modiﬁed Tyrode
solution contained (in mM): NaCl 121, KCl 4, CaCl2 1.3, MgCl2 1,
HEPES 10, NaHCO3 25, glucose 10 at pH=7.35. Osmolarity of the
modiﬁed Tyrode solution was 300 ± 3mOsm, measured with a vapor
pressure osmometer (Vapro 5520, Wescor Inc., Logan, UT, USA).
During experiments the bath temperature was set to 37 °C by a tem-
perature controller (Cell MicroControls, Norfolk, VA, USA). The cells
were visualized by an inverted microscope (Eclipse TE2000-U or
Diaphot 300, Nikon, Japan) placed in a Faraday cage on an anti-vi-
bration table. Electrical signals were recorded with intracellular am-
pliﬁers (MultiClamp 700A or 700B, Molecular Devices, Sunnyvale, CA,
USA) and recorded with pClamp 10 software (Molecular Devices) after
analogue-digital conversion (Digidata 1440A or 1332, Molecular
Devices). Electrodes were fabricated from borosilicate glass having tip
resistances of 2–3MΩ after ﬁlling with pipette solution. Membrane
currents were recorded using the whole-cell conﬁguration of the patch-
clamp technique. After establishing high (1–10 GΩ) resistance seal by
gentle suction, the cell membrane beneath the tip of the electrode was
disrupted by further suction or by applying 1.5 V electrical pulses for
1ms. The series resistance was typically 4–8MΩ. Experiments were
discarded when the series resistance changed substantially during the
measurement. The regular pipette solution contained (in mM): K-as-
partate 120, KCl 30, MgATP 3, HEPES 10, Na2-phosphocreatine 3,
EGTA 0.01, cAMP 0.002, KOH 10 at pH=7.3. The osmolarity of the
pipette solutions was 285mOsm.
2.3.1. Action potential voltage clamp
Action potential voltage clamp (APVC) experiments were conducted
according to the methods described previously [28–30]. Two types of
APVC arrangements were applied. In the majority of experiments the
cell's own AP was used as the command voltage (self APVC). In other
experiments a previously recorded “canonic” midmyocardial action
potential (possessing average parameters and conﬁguration) was ap-
plied to the voltage clamped cells as command signal (canonic APVC).
Current traces were recorded continuously under reference conditions
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(I0), and after 5min superfusion with the speciﬁc Na+ channel inhibitor
tetrodotoxin (ITTX). INa-late was deﬁned as a TTX-sensitive current, ob-
tained by subtracting the post-TTX traces from the reference traces (INa-
late = I0− ITTX). During the analysis of INa-late the initial 15ms after the
AP upstroke (as indicated) was excluded from evaluation in order to
omit the early Na+ current peak. To account for trace-to-trace ﬂuc-
tuations and to reduce noise, 20 consecutive INa-late traces were aver-
aged, and the averaged curve was used for later analysis. INa-late was
usually normalized to cell capacitance, determined in each cell by ap-
plying hyperpolarizations from +10 to −10mV for 15ms.
2.3.2. Conventional voltage clamp
Conventional voltage clamp experiments, using rectangular com-
mand pulses, were performed with canine, human and guinea pig
ventricular myocytes in order to study the density and inactivation
characteristics of INa-late. In this case the external solution contained
1 μM nisoldipine to block L-type Ca2+ current and the rapid and slow
delayed rectiﬁer K+ currents were blocked by application of 0.1 μM
dofetilide and 0.5 μM HMR-1556, respectively. Test pulses were
clamped to−20mV from the holding potential of−120mV before and
after superfusion with 20 μM TTX, and INa-late was considered as a result
of the pharmacological subtraction. These INa-late records (after exclu-
sion of the initial 50ms period) were ﬁtted to a monoexponential
function.
2.3.3. Recording of action potentials from multicellular preparations
Left ventricular trabeculae, dissected from canine, human and
guinea pig ventricles, were used for AP recording. Multicellular pre-
parations were selected to prevent the limitations inherent to single
myocyte studies, like absence of intercellular clefts, potential damage to
channel proteins etc., allowing better simulation of in vivo conditions.
Transmembrane potentials were recorded using 3M KCl ﬁlled sharp
glass microelectrodes having tip resistance between 10 and 20MΩ.
These electrodes were connected to the input of a high impedance
electrometer (MDE GmbH, Heidelberg, Germany). Preparations were
paced through a pair of platinum electrodes using 1ms wide rectan-
gular current pulses with twice threshold amplitude. The pacing cycle
length was initially set to 1 s for at least 60min allowing the prepara-
tions to equilibrate before starting the measurement. After taking re-
cordings at this steady 1 s cycle length, the pacing cycle length was
sequentially varied between 0.3 and 5 s. The 25th AP was measured at
each cycle length, and the cycle length was then changed so that quasi-
steady-state frequency-response relations could be obtained rapidly.
APs were digitized at 100 kHz using an ADA 3300 data acquisition
board (Real Time Devices Inc., State Collage, PA, USA) and stored for
later analysis. After taking control records at each cycle length the
preparations were superfused with 2 μM TTX for 20min and the entire
protocol was repeated in the presence of TTX. Eﬀorts were made to
maintain the same impalement throughout each experiment. If, how-
ever, an impalement became dislodged, adjustment was attempted, and
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Fig. 1. Concentration-dependent eﬀect of tetrodotoxin (TTX) in isolated canine ventricular myocytes under APVC conditions. For the sake of better comparability
canonic APs were used as command signals (shown in the upper row). Furthermore, in order to exclude any contamination by L-type Ca2+ current, these experiments
were performed in the presence of 1 μM nisoldipine. A: Representative records of INa-late dissected by increasing concentrations of TTX. Exposure to TTX lasted for
5 min in each case. B and C: Concentration-response curves obtained for INa-late measured 15ms after the AP upstroke (B), and the net charge mediated by the current
(C). The solid curve was obtained by ﬁtting data to the Hill equation. Symbols and bars denote mean ± SEM values, numbers in parentheses indicate the number of
cells studied, derived from 5 animals.
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if the characteristics of the re-established impalement deviated
by<5% from the previous measurement, the experiment continued.
2.4. Statistics
Results are expressed as mean ± SEM values, the number of myo-
cytes or multicellular preparations studied/derived from the number of
animals is given in parenthesis. In the graphs individual data are de-
noted by blue dots. Statistical signiﬁcance of diﬀerences was evaluated
using one-way ANOVA followed by Student's t-test. Diﬀerences were
considered signiﬁcant when p was< 0.05.
Chemicals used in the experiments were obtained from Sigma-
Aldrich Co. (St. Louis, MO, USA).
3. Results
Primarily the optimal TTX concentration for dissection INa-late in
canine ventricular myocytes had to be determined in order to ﬁnd a
TTX concentration that is suitable to excise a suﬃciently large portion
of INa-late allowing visualization of the true proﬁle of the current.
Representative records presented in Fig. 1.A indicate that the eﬀect of
TTX tends to saturate at the concentration of 10 μM. Based on the
concentration-response curves obtained by ﬁtting these data to the Hill
equation (Fig. 1.B, C) 10 μM TTX caused an approximately 87% in-
hibition of the current. Therefore 10 μM TTX was chosen to dissect INa-
late in the forthcoming voltage clamp experiments bearing in mind that
this approach is likely to somewhat underestimate the density and in-
tegral of INa-late. Accordingly, the relative contribution of the high TTX-
aﬃnity “neuronal” Na+ channels were not monitored, i.e. the eﬀects of
lower (nanomolar) TTX concentrations were not studied. This may
distort somewhat the EC50 values obtained for TTX in Fig. 1.B and C.
These measurements were performed in the presence of 1 μM nisoldi-
pine to suppress L-type Ca2+ current, since large concentrations of TTX
have been shown to inhibit Ca2+ current as well [31,32].
As has been shown in Fig. 1 (canonic APVC in nisoldipine) and
Fig. 2.A (self APVC without nisoldipine), canine INa-late displayed a
“decrescendo” proﬁle, i.e. its amplitude decreased monotonically
during the time course of the AP, in contrast to guinea pig ventricular
myocytes, where the amplitude of the current was increasing during the
plateau and declined only on terminal repolarization (Fig. 2.D, “cres-
cendo proﬁle”). These diﬀerences are also reﬂected by the current-
voltage relations (phase-plane trajectories) obtained under the APs in
canine and guinea pig cells (Fig. 2.B and E). More quantitative ap-
proach to demonstrate the proﬁle of INa-late is to measure the density of
the TTX-sensitive current at 20%, 50% and 100% of APD, where the
APD at 90% repolarization (APD90) was considered as 100% (Fig. 2.C
and F). Accordingly, the density of INa-late at 20% APD was
−0.52 ± 0.09 pA/pF in dog versus the−0.21 ± 0.05 pA/pF in guinea
pig (p < .05), while at 100% APD INa-late had a greater density in
guinea pig than dog (−0.78 ± 0.07 versus− 0.03 ± 0.02 pA/pF,
p < .05). At 50% APD the densities were not signiﬁcantly diﬀerent in
the two species. Although the charge carried by INa-late was higher in
guinea pig than in dog (86.2 ± 10.8 fC/pF, n=20/9 versus
67.1 ± 9.2 fC/pF, n=7/4, p < .05) these current integrals were in a
similar range.
As already mentioned above, INa-late current proﬁles in canine
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Fig. 2. True proﬁles of INa-late recorded in canine (A-C) and guinea pig (D-F) ventricular cells under self APVC conditions. Currents were dissected by 10 μM TTX. A,D:
Representative records displaying INa-late proﬁles (command APs above). B,E: Phase-plane trajectories obtained from the same records. C,F: Densities of INa-late
measured at 20%, 50% and 100% of APD, where APD90 was deﬁned as 100%. Symbols and bars are mean ± SEM values, blue dots represent individual data,
numbers in parentheses indicate the number of myocytes/number of animals studied.
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cardiomyocytes were determined under APVC conditions in two
slightly diﬀerent experimental groups. In the ﬁrst group canonic APVC
was used and INa-late was determined in the presence of 1 μM nisoldipine
(Fig. 1, n=9/5). In the second group self APVC was used without ni-
soldipine (Fig. 2.A-C, n=7). Although the values were somewhat
smaller in the presence of nisoldipine, no signiﬁcant diﬀerences were
found between the two groups at 20%, 50% or 100% APD
(−0.48 ± 0.08 versus− 0.52 ± 0.09 pA/pF, −0.30 ± 0.06
versus− 0.34 ± 0.06 pA/pF and− 0.06 ± 0.02 versus− 0.03 ±
0.02 pA/pF, respectively). The integrals were also similar (63.1 ± 9.2
fC/pF, n=9/5 versus 67.1 ± 9.2 fC/pF, n= 7/4, respectively, N.S.).
This comparison suggests that 10 μM concentration of TTX does not
interfere with the L-type Ca2+ current.
Since AP conﬁguration has been shown to inﬂuence current proﬁles
under APVC conditions [28,29], attempts were made to convert the
decrescendo type canine INa-late into a crescendo proﬁle, characteristic
of guinea pig myocytes. Therefore, duration-matched canonic guinea
pig APs (Fig. 3.B,E) and voltage ramps resembling the ramp-like plateau
of guinea pig cells (Fig. 3.C,F) were applied as command signals to
canine cells. The ramp started from −80mV, spent 10ms at +40mV
and decayed to −20mV during 200ms. None of these interventions
were capable to convert the canine decrescendo current proﬁle to a
crescendo guinea pig-like INa-late proﬁle. The current integrals were also
similar in canine cells independently of the canine or guinea pig origin
of the command AP (63.1 ± 9.2 fC/pF, n=9/5 versus 65.4 ± 10.7
fC/pF, n=6/5, N.S.).
The sea-anemone toxin (ATX-II) has been shown to induce a current
in cardiac tissues resembling INa-late by removing the fast inactivation
machinery of Na+ channels [33]. In guinea pig myocytes the proﬁle of
the TTX-sensitive current was similar in the absence and presence of
10 nM ATX-II (Fig. 4.A), although its amplitude was signiﬁcantly in-
creased by ATX-II (compare also Figs. 4.D and 2.F), i.e. the current
followed crescendo kinetics in both cases. In contrast, canine myocytes
usually produced early afterdepolarizations when exposed to 10 nM
ATX-II for 3min (not shown), therefore the canine cells were treated
with a lower, 1 nM concentration of ATX-II. The TTX-sensitive current
in these canine cells displayed a plateau-like shape, i.e. the current
densities were largely similar at 20%, 50% and 100% APD in the pre-
sence of ATX-II (Fig. 4.B,E). This current proﬁle, containing the sum of
baseline INa-late plus the ATX-II-induced current component, was
markedly diﬀerent from that recorded in the absence of ATX-II (com-
pare Figs. 4.E and 2.C). Therefore, in another series of experiments,
where the ATX-II-induced current alone was visualized, the ATX-II-in-
duced current showed moderate crescendo characteristics in canine
myocytes (Fig. 4.C,F). The TTX-sensitive current integrals were sig-
niﬁcantly larger in the presence of ATX-II (1 nM in canine and 10 nM in
guinea pig cells) comparing to untreated cells: 102 ± 13 fC/pF, n=7/
4 versus 67 ± 9 fC/pF, n=7/4 in canine; and 145 ± 19 fC/pF, n=5/
3 versus 86 ± 11 fC/pF, n=20/9 in guinea pig myocytes, p < .05 for
both. The duration of action potentials (APD90) was signiﬁcantly in-
creased by 1 nM ATX-II in canine cells from 214 ± 13ms to
257 ± 17ms (lengthening of 43.2 ms, n=7/4, p < .05), in contrast
to guinea pig myocytes, where the increase induced by 10 nM ATX-II
(from 192 ± 15 to 212 ± 20ms, lengthening of 19.5ms, n=5/3),
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Fig. 3. Eﬀect of the shape of command voltage on the proﬁle of INa-late in canine myocytes.
A-C: Representative sets of records displaying command voltage protocols (upper row) and the recorded INa-late proﬁles dissected by 10 μM TTX in the presence of
1 μM nisoldipine (lower row). A canonic dog AP was delivered to a canine cell in panel A, in B a canonic guinea pig AP was applied to a canine cell, while in C a
decaying voltage ramp was used as a command signal. D-F: INa-late densities measured at 20%, 50% and 100% of APD (100%=APD90) under conditions shown in
panels A-C. Symbols and bars are mean ± SEM values, blue dots represent individual data, numbers in parentheses indicate the number of myocytes/number of
animals studied.
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was not signiﬁcant statistically. These results clearly demonstrate that
canine myocytes are much more sensitive to ATX-II that the guinea pig
cells, and more importantly, the proﬁle of the ATX-II-induced current is
diﬀerent from the native INa-late in canine myocytes.
In the followings the proﬁles (under self APVC conditions) and the
kinetic properties (using conventional voltage clamp techniques) of INa-
late were compared in human, canine and guinea pig ventricular cells
(Fig. 5). The 20 μM TTX-sensitive currents were similarly shaped in all
types of myocytes when the membrane potential was switched from the
holding potential of −120mV to the test potential of −20mV in the
presence of 1 μM nisoldipine (Fig. 5.A-C). When the decay of TTX-
sensitive current was ﬁtted to a monoexponential function (excluding
the initial 50ms period) the inactivation time constants were
60 ± 3ms (n=13/7) in canine, 67 ± 5ms (n=5/3) in human, and
155 ± 16ms (n=5/3) in guinea pig cells. Thus the time course of
inactivation of INa-late was similar in human and canine myocytes, but
was signiﬁcantly (p < .05) slower in guinea pig. The corresponding
current densities (obtained also by the monoexponential ﬁtting proce-
dure) were− 0.47 ± 0.05 pA/pF in human, −0.56 ± 0.04 pA/pF in
canine and− 0.54 ± 0.14 pA/pF in guinea pig myocytes, which values
were not signiﬁcantly diﬀerent. Representative INa-late proﬁles recorded
from a human, canine and guinea pig myocyte under self APVC con-
ditions are presented in Fig. 5.D-F. These current proﬁles were also very
similar in canine and human cells (both sharing the decrescendo INa-late
proﬁle), while markedly diﬀerent from the crescendo type INa-late in
guinea pig.
The rate-dependent eﬀects of TTX on AP morphology in
multicellular ventricular preparations, obtained from the three species,
is demonstrated in Fig. 6. All preparations were superfused with 2 μM
TTX and the measurements were performed after equilibration. APD
was shortened by TTX at each cycle length. The TTX-induced short-
ening, recorded at the cycle length of 1 s, was the largest (67 ± 16ms,
n=4/3) in human, intermediate (21 ± 4ms, n=5/5) in canine and
the smallest (11 ± 3, n=7/7) in guinea pig preparations. The resting
membrane potential and the amplitude of AP were not altered by TTX.
The maximum velocity of depolarization (dV/dtmax) was moderately
reduced by TTX from 310 ± 48 to 259 ± 24 V/s in human, from
231 ± 40 to 169 ± 33 V/s in canine, and from 226 ± 32 to
176 ± 21 V/s in guinea pig, however, these changes failed to reach the
level of signiﬁcance – except for the canine preparations.
4. Discussion and conclusions
This is the ﬁrst study to demonstrate the proﬁles of human and
canine ventricular INa-late under self APVC conditions. From this per-
spective our results are in line with those of Murphy et al. [23] who
have shown the proﬁle of canine INa-late using canonic APs. Regarding
undiseased human ventricular cells, this is the ﬁrst report using the
APVC technique. Our most important ﬁnding was to demonstrate that
canine myocytes can be used as a reasonably good model to study
human INa-late - in contrast to myocytes originating from other mammals
including guinea pigs, rabbits and pigs, since all in these latter species
the current displays a crescendo proﬁle [18–20]. Important implication
of this interspecies diﬀerence is that the relative contribution of INa-late
C
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Fig. 4. Eﬀect of ATX-II on the TTX-sensitive current proﬁle in guinea pig and canine ventricular cells. In guinea pig myocytes (A, D) the TTX-sensitive current proﬁle
was similarly shaped (crescendo) in the absence (red records) or presence (black records) of 10 nM ATX-II, while in canine cells (B, E) the current proﬁle was
modiﬁed by 1 nM ATX-II. The control TTX-sensitive current records (red) are derived from diﬀerent cells and presented exclusively for the sake of better comparison.
The proﬁle of the ATX-II-induced current in canine cells is displayed in panels C and F.. Bottom panels display Na+ current densities measured in the presence of
ATX-II (D, E) and absence of ATX-II (F) at 20%, 50% and 100% of APD, where 100%=APD90. Symbols and bars are mean ± SEM values, blue dots represent
individual data, numbers in parentheses indicate the number of myocytes/number of animals studied.
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to action potential morphology (with the concomitant Na+ and Ca2+
load resulting in increased arrhythmia propensity) increases with
lengthening of APD in the “crescendo” group in contrast to the “de-
crescendo” situation, and vice versa, it will be relatively smaller at
shorter APDs. More explicitly, INa-late is the largest in amplitude at the
time of terminal repolarization in the “crescendo” type species, conse-
quently, a given prolongation of APD (eg. due to application of a HERG
channel inhibitor) is expected to cause a greater extra inward INa-late
current (together with larger Na+ and Ca2+ load), which in turn, may
magnify the APD lengthening eﬀect of the K+ channel inhibitor. Since
INa-late is practically inactivated at this time in the “decrescendo” type
preparations, changes in APD will barely modify the magnitude of Na+
entry via INa-late. Using similar argumentation, the therapeutic eﬀects of
INa-late inhibitors (including the shortening of APD and reduction of
cellular Na+ and Ca2+ content) is expected to be less pronounced in
canine and human myocardium than in similar preparations from
guinea pigs, rabbits and pigs. This should be taken into account when
the results of pharmacological studies on INa-late inhibitors or modiﬁers
are interpreted or extrapolated to human, since some studies with such
compounds have been performed in species displaying crescendo INa-late
proﬁles [34–36]. Based on the present results, canine ventricular tissues
or myocytes are suggested for pharmacological studies with drugs in-
teracting with INa-late.
We have also revealed why the guinea pig INa-late is growing under
the AP plateau, while canine and human INa-late decreases during the
time course of the AP. In canine and human myocytes the inactivation
time constant of INa-late was in the range of 60–67ms at −20mV,
consequently the current became practically fully inactivated by the
time of terminal repolarization. In contrast, the decay time constant
was much longer (156ms) in guinea pig, thus the inactivation was slow
enough to leave a signiﬁcant portion of Na+ cannels open by the time
of terminal repolarization. Consequently, the increasing inward driving
force acting on Na+ ions could increase the amplitude of INa-late during
the monotonic slow repolarization in guinea pig (and likely also in
rabbit and pig). The well-known crescendo INa-late proﬁle in guinea pig
was originally explained with the non-equilibrium gating theory of
Clancy et al. [37]. This model predicts the accumulation of INa-late
during the plateau as a consequence of the ramp-like conﬁguration of
phase-2 repolarization of the guinea pig AP. However, application of
guinea pig APs as well as repolarizing ramps as command signals failed
to convert the decrescendo INa-late proﬁle of canine cells to crescendo,
indicating that it is not the AP conﬁguration, but rather the 2.5-fold
slower inactivation kinetics, revealed by the conventional voltage
clamp experiments, that accounts for the crescendo INa-late proﬁle in
guinea pig. Since a portion of INa-late is attributed to the function of non-
cardiac Na+ channels in the canine heart [38], it is possible that the
type or relative contribution of these TTX-sensitive channels or var-
iances in their regulatory subunits are diﬀerent in dogs (and humans)
versus guinea pigs (and pigs or rabbits). However, elucidating the de-
tails behind the diﬀerent inactivation kinetics of INa-late among various
species warrants further studies.
Here is to be mentioned that there is a wide variety of SCN5 mu-
tations, responsible for LQT3 syndrome, and depending on the site and
type of mutation many parameters of Na+ channel gating, including the
rate of inactivation and recovery as well as the voltage dependence of
activation and inactivation, may be altered, however, augmentation of
INa-late is a critical and common feature in all cases [39]. Since only a
very small fraction of the total Na+ cahnnel population may contribute
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to generation of INa-late (compare the few tens of pA amplitude of INa-late
with the several nA amplitude of the peak Na+ current), the macro-
scopic changes in INa gating are less relevant from the pathophysiolo-
gical point of view than the actual magnitude of INa-late.
Another important result of the present study was to show that the
proﬁle of the ATX-II-induced current recorded under APVC conditions
in canine cells is markedly diﬀerent from the shape of native canine INa-
late, since the ATX-II-induced current displayed a crescendo proﬁle in
both species – similar to the native INa-late of guinea pig, rabbit and
porchine hearts, but diﬀerent from the native INa-late recorded from
canine myocytes. This may be related to the well-known fact that ATX-
II slows inactivation of Na+ channels [33]. ATX-II is widely used for
mimicking pharmacologically the consequences of an augmented INa-
late, which is often seen under pathological conditions [5] and ATX-II is
a widely used pharmacological tool to model this. In canine myocytes
(i.e. in the cells appearing to be the best model for studying human INa-
late), however, this approach may be misleading due to the diﬀerences
observed between the native INa-late and ATX-II-induced current pro-
ﬁles. As a consequence, ATX-II modiﬁed Na+ channels might also diﬀer
from the native channels in their in drug-sensitivity, making results
obtained in the presence of ATX-II diﬃcult to interpret.
APDs recorded from multicellular canine, human and guinea pig
preparations were shortened by 2 μM TTX, which eﬀect was the largest
in human, intermediate in canine and the smallest in guinea pig pre-
parations. This sequence can not be explained by the known (and
presently described) properties of INa-late, since the current densities and
integrals were largely similar in the three species. It is more likely
therefore that the magnitude of the TTX-induced shortening depends on
the actual repolarization reserve of the myocardium [40,41], which is
the smallest in human, intermediate in canine, and with the strong IKs is
the largest in guinea pig ventricular myocardium [42,43]. This is a
further argument in support of using canine myocytes for modeling
human INa-late. This interspecies diﬀerence (i.e. dog vs. guinea pig) in
repolarization reserve may explain also the higher ATX-II-sensitivity of
dog comparing to guinea pig. In canine myocytes 1 nM ATX-II caused
twice greater lengthening of AP than 10 nM ATX-II in guinea pig, while
10 nM ATX-II initiated early afterdepolarizations in canine cells.
In summary, we conclude that canine myocytes represent a rea-
sonably suitable model of human ventricular cells regarding the prop-
erties of INa-late. However, further detailed studies are required to de-
scribe the gating kinetics of INa-late.
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